These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14998818)

  • 1. Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for down syndrome: results of the French National Perinatal Survey of 1998.
    Khoshnood B; Blondel B; de Vigan C; Bréart G
    Am J Public Health; 2004 Mar; 94(3):484-91. PubMed ID: 14998818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Socioeconomic disparities for maternal serum screening of Down's syndrome: trends between 1998 and 2003 in France].
    Grupposo MC; Khoshnood B; Supernant K; Blondel B
    J Gynecol Obstet Biol Reprod (Paris); 2008 May; 37(3):246-55. PubMed ID: 18328634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does women's place of birth affect their opportunity for an informed choice about Down syndrome screening? A population-based study in France.
    Anselem O; Saurel-Cubizolles MJ; Khoshnood B; Blondel B; Sauvegrain P; Bertille N; Azria E;
    BMC Pregnancy Childbirth; 2021 Aug; 21(1):590. PubMed ID: 34461849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in medical technology and creation of disparities: the case of Down syndrome.
    Khoshnood B; De Vigan C; Vodovar V; Bréart G; Goffinet F; Blondel B
    Am J Public Health; 2006 Dec; 96(12):2139-44. PubMed ID: 17077393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population.
    Schoonen M; Wildschut H; Essink-Bot ML; Peters I; Steegers E; de Koning H
    Patient Educ Couns; 2012 Jun; 87(3):351-9. PubMed ID: 22030253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study.
    Li C; Shi L; Huang J; Qian X; Chen Y
    BMC Health Serv Res; 2016 Jan; 16():8. PubMed ID: 26762138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term trends for socio-economic differences in prenatal diagnosis of Down syndrome: diffusion of services or persistence of disparities?
    Khoshnood B; De Vigan C; Blondel B; Vodovar V; Cadio E; Goffinet F
    BJOG; 2008 Aug; 115(9):1087-95. PubMed ID: 18518869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit.
    Dormandy E; Hooper R; Michie S; Marteau TM
    J Med Screen; 2002; 9(3):109-14. PubMed ID: 12370321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnant women's views on how to promote the use of a decision aid for Down syndrome prenatal screening: a theory-informed qualitative study.
    Agbadjé TT; Menear M; Dugas M; Gagnon MP; Rahimi SA; Robitaille H; Giguère AMC; Rousseau F; Wilson BJ; Légaré F
    BMC Health Serv Res; 2018 Jun; 18(1):434. PubMed ID: 29884169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variations in prenatal screening across Australia: stepping towards a national policy framework.
    O'Leary P; Breheny N; Reid G; Charles T; Emery J
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):427-32. PubMed ID: 16953858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France].
    Dupont JM; Simon-Bouy B; Zebina A; Pessione F; Royère D; Doco-Fenzy M;
    Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):152-157. PubMed ID: 28258854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.
    Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM
    BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are adolescents' decisions about prenatal screening for Down syndrome informed? A controlled, prospective study.
    Wynter KH; Rowe HJ; Fisher JR; Lee M; Quinlivan JA
    J Pediatr Adolesc Gynecol; 2011 Feb; 24(1):29-34. PubMed ID: 20709585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recourse to amniocentesis after the age of 38. Factors related to access to medical care].
    Czernichow P; Moirot H; Pierre M; Daniel P; Hemet J
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(6):729-36. PubMed ID: 2968393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum screening for anomalies in pregnancy: reasons for acceptance or refusal of the test.
    Gokhale LS; Cietak KA
    J Obstet Gynaecol; 2002 Jul; 22(4):392-3. PubMed ID: 12521462
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent to serum screening for Down syndrome: are women given adequate information?
    Gekas J; Gondry J; Mazur S; Cesbron P; Thepot F
    Prenat Diagn; 1999 Jan; 19(1):1-7. PubMed ID: 10073897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.